Herbert Ludewick

Dr. Herbert Ludewick

Heart and Lung Research Institute, Institute for Respiratory Health

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
BBBenjamin Bartlett
Benjamin Bartlett
HLHerbert Ludewick
Herbert Ludewick
SLSilvia Lee
Silvia Lee
SVShipra Verma
Shipra Verma
RFRoslyn J. Francis
Roslyn J. Francis
GDGirish Dwivedi
Girish Dwivedi
Acute coronary syndrome (ACS) describes a range of conditions associated with the rupture of high-risk or vulnerable plaque. Vulnerable atherosclerotic plaque is associated with many changes in its microenvironment which could potentially cause rapid plaque progression. Present-day PET imaging presents a plethora of radiopharmaceuticals designed to image different characteristics throughout plaque progression. Improved knowledge of atherosclerotic disease pathways has facilitated a growing number of pathophysiological targets for more innovative radiotracer design aimed at identifying at-risk vulnerable plaque and earlier intervention opportunity. This paper reviews the efficacy of PET imaging radiotracers 18F-FDG, 18F-NaF, 68Ga-DOTATATE, 64Cu-DOTATATE and 68Ga-pentixafor in plaque characterisation and risk assessment, as well as the translational potential of novel radiotracers in animal studies. Finally, we discuss our murine PET imaging experience and the challenges encountered.